Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer

被引：8
|
作者：
Chan, Andrew [1 ]
Teoh, Daien [1 ]
Singhera, Paul [1 ]
Hartley, Andrew [1 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
来源：
RADIOTHERAPY AND ONCOLOGY | 2009年 / 93卷 / 03期
关键词：
SQUAMOUS-CELL CARCINOMA;
D O I：
10.1016/j.radonc.2009.05.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：654 / 654
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients
    Fayette, Jerome
    Bonnin, Nathalie
    Ferlay, Celine
    Lallemant, Benjamin
    Ramade, Antoine
    Favrel, Veronique
    Zrounba, Philippe
    Chabaud, Sylvie
    Pommier, Pascal
    Poupart, Marc
    Ceruse, Philippe
    ANTI-CANCER DRUGS, 2013, 24 (06) : 623 - 629
  • [22] Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma
    Driessen, Chantal M. L.
    Janssens, Geert O.
    van der Graaf, Winette T. A.
    Takes, Robert P.
    Merkx, Thijs A. W.
    Melchers, Willem J. G.
    Kaanders, Hans A. M.
    van Herpen, Carla M. L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E559 - E565
  • [23] Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence
    Numico, Gianmauro
    Franco, Pierfrancesco
    Cristofano, Antonella
    Migliaccio, Fernanda
    Spinazze, Silvia
    Silvestris, Nicola
    Cante, Domenico
    Sciacero, Piera
    La Porta, Maria Rosa
    Girelli, Franco
    Ricardi, Umberto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 85 (02) : 112 - 120
  • [24] Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer
    Levy, Antonin
    De Felice, Francesca
    Bellefqih, Sara
    Guigay, Joel
    Deutsch, Eric
    Nguyen, France
    Blanchard, Pierre
    Tao, Yungan
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E905 - E910
  • [25] Concurrent chemotherapy and radiotherapy for head and neck cancer
    Burri, Ryan J.
    Lee, Nancy Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 293 - 302
  • [26] Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
    Chitapanarux, Imjai
    Tharavichitkul, Ekkasit
    Kamnerdsupaphon, Pimkhuan
    Pukanhapan, Nantaka
    Vongtama, Roy
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (06) : 1110 - 1117
  • [27] Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer
    Budach, V.
    Becker, E. -T.
    Boehmer, D.
    Badakhshi, H.
    Jahn, U.
    Wernecke, K. -D.
    Stromberger, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (03) : 250 - 255
  • [28] Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients
    Franzese, Ciro
    Fogliata, Antonella
    Franceschini, Davide
    Navarria, Pierina
    Cozzi, Luca
    Tomatis, Stefano
    De Virgilio, Armando
    Spriano, Giuseppe
    Scorsetti, Marta
    LARYNGOSCOPE, 2020, 130 (04) : E163 - E170
  • [29] Compliance, toxicity and efficacy in weekly versus 3-weekly cisplatin concurrent chemoradiation in locally advanced head and neck cancer
    Muzumder, Sandeep
    Srikantia, Nirmala
    Vashishta, Ganesha Dev
    Udayashankar, Avinash H.
    Raj, John Michael
    Sebastian, M. G. John
    Kainthaje, Prashanth Bhat
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2019, 18 (01) : 21 - 25
  • [30] Toxicity and efficacy of cetuximab associated with several modalities of IMRT for locally advanced head and neck cancer
    Bibault, J. -E.
    Morelle, M.
    Perrier, L.
    Pommier, P.
    Boisselier, P.
    Coche-Dequeant, B.
    Gallocher, O.
    Alfonsi, M.
    Bardet, E.
    Rives, M.
    Calugaru, V.
    Chajon, E.
    Noel, G.
    Mecellem, H.
    Perol, D.
    Dussart, S.
    Giraud, P.
    CANCER RADIOTHERAPIE, 2016, 20 (05): : 357 - 361
12345